A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

216

Participants

Timeline

Start Date

May 8, 2024

Primary Completion Date

November 9, 2026

Study Completion Date

December 9, 2026

Conditions

Advanced Solid Tumors

Interventions

DRUG

BAT8010 for Injection

Intravenous

DRUG

BAT1006 for Injection

Intravenous

Trial Locations (1)

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou